A simple change in how primary care clinics approach weight management is delivering big public health wins. PATHWEIGH lets patients openly request help and gives doctors the tools to focus entire ...
Obesity is a major public health challenge worldwide and a key contributor to cardiometabolic morbidity and mortality. Despite lifestyle interventions and conventional pharmacotherapy, long-term ...
Wegovy is a Food and Drug Administration-approved weight loss medication for people with obesity or those who are overweight with weight-related health conditions. In recent years, interest in GLP-1 ...
White adipose tissue (WAT) is a highly plastic tissue that plays an important role in systemic energy homoeostasis by serving as the major depot for storage of metabolic energy as well as an endocrine ...
At the end of a seemingly ubiquitous commercial for telehealth company Ro, a characteristically flabbergasted Charles Barkley speaks for us all when he remarks, “Wait, you’re telling me they have a ...
Medicare has delayed a program for older Americans that would've required participating insurance companies to cover GLP-1 weight loss drugs such as Novo Nordisk's Wegovy and Eli Lilly's Zepbound.
Forbes contributors publish independent expert analyses and insights. Across the earlier articles in this series, we developed a framework for understanding why weight loss and regulation is far more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results